Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A genetics‐based biomarker risk algorithm for predicting risk of Alzheimer's disease

1 Jan 2016

Abstract excerpt

BACKGROUND: A straightforward, reproducible blood-based test that predicts age dependent risk of Alzheimer's disease (AD) could be used as an enrichment tool for clinical development of therapies. This study evaluated the prognostic performance of a genetics-based biomarker risk algorithm (GBRA) established on a combination of Apolipoprotein E (APOE)/Translocase of outer mitochondrial membrane 40 homolog (TOMM40)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to Functional Brain Connectivity Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27047990
DOI: 10.1016/j.trci.2015.12.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A genetics‐based biomarker risk algorithm for predicting risk of Alzheimer's diseasePMID 27047990Read ↗

New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics.Semantic proximity Read ↗

Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s diseaseSemantic proximity Read ↗

An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Aβ1-42 Ratio in ApoE4-Negative Mild Cognitive Impairment Patients.Semantic proximity Read ↗

Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid.Semantic proximity Read ↗

Genetic architecture of plasma Alzheimer disease biomarkersSemantic proximity Read ↗

Classification and deep-learning–based prediction of Alzheimer disease subtypes by using genomic dataSemantic proximity Read ↗

Alzheimer’s disease: diagnostics, prognostics and the road to preventionSemantic proximity Read ↗

Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer's DiseaseSemantic proximity Read ↗

Shared Genetic Background Between Cerebrospinal Fluid Biomarkers and Risk for Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.Semantic proximity Read ↗

Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer's Disease and Reconstruction of Relevant Biological Mechanisms.Semantic proximity Read ↗

Standardized Comparison of Clinical, Cognitive, Genetic, Neuroimaging, and Fluid Biomarkers for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer’s DiseaseSemantic proximity Read ↗

Identifying healthy individuals with Alzheimer’s disease neuroimaging phenotypes in the UK BiobankSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.